for the right therapeutic approach. The current management of anemia includes the oral and parenteral routes through which iron is supplemented and parenteral iron therapy is given intravenous from the second trimester. In addition to the supplementation, diet and nutrition plays an important role and this should be properly communicated to all pregnant women for preventing anemia in pregnancy.
According to CDC, a 30 mg per day iron supplement should be started at the first prenatal visit. Though recommendations varies based on the regions. British guidelines do not recommend any routine iron supplementation in pregnancy, whereas WHO advises 30-60 mg of elemental iron per day for all pregnant women. WHO also states that, when daily iron intake is not possible due to gastrointestinal side effects, weekly intermittent oral iron supplementation can be implemented. According to the association of Nutrition, the (RDA) of iron for a pregnant woman in third trimester is 30 mg/day. For all the pregnant women who are native to the areas of prevalence of hookworm/Trichuris, WHO recommends routine deworming using single dose Albendazole (400 mg) or mebendazole (500mg). In Ayurvedic science, Garbhini Pandu or the gestational anemia is treated effectively.
Conclusion
One prevalent health problem that affects many pregnant women in underdeveloped nations is gestational anaemia, which calls for quick treatment to preserve the lives of both the mother and the unborn child. An ancient Indian science called Ayurveda offers extensive descriptions of pregnancy, labour, and the management issues that arise, placing a greater emphasis on women and their health. Ayurvedic science's description of Garbhini Pandu is associated with gestational anaemia. The ancient experts have successfully treated Garbhini Pandu since ancient times, and they are still treating them today. The current investigation has concentrated on defining the notions of Garbhini, its treatment, and its relationship to gestational anaemia in contemporary medicine.
References
1. Milman N. Anemia-still a major health problem
in many parts of the World! Ann Hematol. 2011;90(4):369-377.
2. World Health Organization. Worldwide prevalence of anaemia 1993-2005. WHO Global Database on Anaemia. Switzerland; 2008. Available from: http://whqlibdoc.who.int/publications/2008/9789241596657_eng.pdf.
3. Milman N, Agger AO, Nielsen OJ. Iron supplementation during pregnancy. Effect on iron status markers, serum erythropoietin and human placental lactogen. A placebo controlled study in 207 Danish women. Dan Med Bull. 1991;38(6):471-476.
4. Milman N, Bergholt T, Eriksen L, et al. Iron prophylaxis during pregnancy - How much iron is needed? A randomized dose-response study of 20–80 mg ferrous iron daily in pregnant women. Acta Obstet Gynecol Scand. 2005;84(3):238–247.
5. Komolafe JO, Kuti O, Ijadunola KT, Ogunniyi SO. A comparative study between intramuscular iron dextran and oral ferrous sulphate in the treatment of iron deficiency anaemia in pregnancy. J Obstet Gynaecol. 2003;23(6):628–631.
6. Pena-Rosas JP, Viteri FE. Effects of routine oral iron supplementation with or without folic acid for women during pregnancy. Cochrane Database Syst Rev. 2006;(3):CD004736.
7. Reveiz L, Gyte GM, Cuervo LG. Treatments for iron deficiency anaemia in pregnancy. Cochrane Database Syst Rev. 2007;(2):CD003094.
8. Danielson BG, Salmonson T, Derendorf H, Geisser P. Pharmacokinetics of iron (III)-hydroxide sucrose complex after a single intravenous dose in healthy volunteers. Arzneimittel-Forschung. 1996;46(6):615–621.
9. Mukherjee PK, Harwansh RK, Bahadur S, et al. Development of Ayurveda - Tradition to trend. School of Natural Product Studies, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India; Research & Development Center, Healthcare Division, Emami Limited, Kolkata, India.